Myopia Control Clinic
UCSF's pediatric Myopia Control Clinic provides expert care for children of all ages and young adults who are nearsighted. In this common vision problem, also called myopia, light doesn't focus correctly on the eye's retina, making close objects look clear while faraway objects look blurry. This condition occurs when the eye grows too long, which can lead to complications that impact sight. Our team of optometrists, ophthalmologists and technicians aims to prevent or slow the progression of your child's myopia through collaborative care based on the best and most current research.
Treatments for your child's myopia may include myopia control glasses (such as the FDA-approved Stellest lenses) , multifocal contact lenses (such as the FDA-approved MiSight lenses) or an eye-drop regimen using low-dose atropine (a prescription medication). We may additionally recommend behavior modifications as part of your child's treatment plan. We also partner with the UC Berkeley Myopia Control Clinic to provide corneal reshaping therapy, or orthokeratology, a nonsurgical method of reshaping the cornea using rigid gas-permeable lenses while sleeping to improve vision. If your child has seen an eye care provider within the previous six months, you have the option of making a virtual appointment. Otherwise, you'll need to schedule an in-person appointment. Come prepared for your visit with a history of prescriptions and eye exam records, if possible, for your child's glasses.
Our locations (2)
Awards & recognition
-
Ranked among the nation's best in 11 specialties
Plan your visit
What to Bring
- History of prescriptions for your child's glasses
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- Be prepared to discuss your child’s typical hobbies and activities
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
Clinical trials
International CRDS Registry
Composite of malignant syncope, ICD shock, cardiac arrest, and sudden cardiac death
Recruiting
More about this study
Registry of Patients Diagnosed With Lysosomal Storage Diseases
Prenatal presentation of symptoms (e.g. hydrops) appearing on fetal imaging such as ultrasound and ECHO.
Recruiting
More about this study
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (C...
The primary objective of this access and distribution protocol is to examine the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not FDA licensed.
Recruiting
More about this study
ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I
Incidence of Adverse Events as assessed by CTCAE (v 5.0)
Recruiting
More about this study
International Registry of Patients With Alpha Thalassemia
Number of fetuses diagnosed with alpha thalassemia who survive to birth, compared to number of fetuses diagnosed with alpha thalassemia who have fetal demise or are terminated in utero. This is measured in number of fetuses alive ...
Recruiting
More about this study
Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid...
Tolerability is defined as the proportion of participants receiving at least one dose of combination gemcitabine and paxalisib with a reported dose-limiting toxicity (DLT) during cycle 1 for all participants in Phase I.
Recruiting
More about this study
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Measured by the presence of radiologically assessable disease by cross-sectional computed tomography (CT) or Magnetic resonance imaging (MRI) imaging and/or by metaiodobenzylguanidine (MIBG) or positron emission tomography (PET) s...
Recruiting
More about this study
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Safety will be measured by those events in the European Safety Surveillance (EUHASS)1: 1. Allergic or other acute events 2. Treatment-emergent side effects of therapy 3. Transfusion transmitted infections 4. Inhibitor ...
Recruiting
More about this study
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
To characterize the safety profile of silmitasertib in combination with chemotherapy
Recruiting
More about this studyStress-free visits
Accommodations. Admissions. Procedure prep. Get the info you need for smoother hospital stays.
Prepare for your child's stay